We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Eel Fluorescent Protein Revolutionizes Bilirubin Assay

By LabMedica International staff writers
Posted on 01 Jul 2013
A fluorescent protein from freshwater eels could serve as the basis for a revolutionary new clinical test for bilirubin, a critical indicator of human liver function, hemolysis, and jaundice.

Bilirubin is a common marker in blood tests where bilirubin is used by doctors to assess liver function and for the assessment of health, including hemolysis, the loss of red blood cells in anemia. More...


Scientists at the RIKEN Brain Science Institute (Wako, Japan) investigated a fluorescent protein harbored by Unagi (Anguilla japonica) the sea-going Japanese freshwater eel. The team cloned a gene from Unagi for an unusual fluorescent protein they named UnaG, for Unagi Green protein, which allows eels to glow in the dark. UnaG is the first fluorescent protein found in vertebrates; previously they were thought to exist only in simple animals like jellyfish.

The unique nature of UnaG is that it needs a natural chemical to activate its powerful green light emission. The compound was identified by the investigators to be bilirubin, a molecule universally used in clinical laboratories around the world as a human blood marker for liver function. By analyzing the structure of UnaG, the team discovered a novel mechanism of fluorescence enabling bilirubin to bind to UnaG and activate its light emission. With this property, they developed a superior new assay for bilirubin with high sensitivity, accuracy, and speed that may become the global clinical standard, and can be used in developing countries where child liver health is a major issue.

The scientists performed large-scale measurements comparing human serum samples spiked with bilirubin (UC-BR) and volunteer blood samples and were able to demonstrate the applicability of the fluorescent method while emphasizing the limitations of conventional methodology. Due to the simplicity, they propose that the method will be helpful to clinical laboratories worldwide who run blood panels including bilirubin, and, in particular, pediatricians and pediatric caregivers who treat low birth weight infants in whom high levels of UC-BR may cause jaundice and kernicterus.

Atsushi Miyawaki, MD, PhD, the senior author concluded, “We believe that UnaG provides an unexpected foothold into several important but currently obscure areas of human health including bilirubin metabolism and muscle physiology during endurance exercise. Before the discovery of UnaG, I couldn't imagine that basic science could have such a direct impact on human health. From a simple eel, we found a new path to the clinic." The study was published on June 20, 2013, in the journal Cell.

Related Links:
RIKEN Brain Science Institute



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.